Neuroendocrine cell hyperplasia of infancy is a rare lung condition that usually affects babies in the first months of life. Early signs of neuroendocrine cell hyperplasia of infancy often include fast breathing, chest retractions, low oxygen levels, and trouble keeping up with feeding or growth. Not everyone will have the same experience. Neuroendocrine cell hyperplasia of infancy often lasts for years, but many children improve slowly over time, and treatment usually focuses on oxygen support, good nutrition, and regular follow-up. Death from neuroendocrine cell hyperplasia of infancy is uncommon in milder cases, but the outlook depends on how severe the breathing problems are and whether other health issues are present.
How many people live with Neuroendocrine cell hyperplasia of infancy?
Worldwide and U.S. prevalence estimates for neuroendocrine cell hyperplasia of infancy, a very rare lung condition seen in babies and young children, are not consistently reported by a single authoritative source. In practice, it is considered ultra-rare, but there is no widely accepted current number for how many people are living with it worldwide or in the United States.
Overview
Neuroendocrine cell hyperplasia of infancySymptoms
Neuroendocrine cell hyperplasia of infancy often causes fast breathing, ongoing low oxygen levels, and a crackly or wheezy sound. Babies may tire during feeding and seem short of breath. Early symptoms of Neuroendocrine cell hyperplasia of infancy can vary.
Outlook and prognosis
Many infants with neuroendocrine cell hyperplasia of infancy improve over time, with easier breathing and less need for oxygen as the lungs grow. Some continue to wheeze or get out of breath in early childhood, so regular follow-up matters.
Causes and risk factors
The cause of neuroendocrine cell hyperplasia of infancy is not fully known, but it likely begins before birth and involves unusual growth of certain lung cells. Neuroendocrine cell hyperplasia of infancy is usually not linked to lifestyle or environmental risks, though rare familial cases suggest a possible genetic contribution.
Genetic influences
For neuroendocrine cell hyperplasia of infancy, genetics are usually not the main driver. Most cases are sporadic, but a small number may be linked to gene changes, especially NKX2-1, so genetic testing is sometimes considered.
Diagnosis
Neuroendocrine cell hyperplasia of infancy is diagnosed using clinical features, especially ongoing fast breathing and low oxygen. Doctors usually confirm the diagnosis of Neuroendocrine cell hyperplasia of infancy with a chest CT scan. Genetic tests may be used to rule out other lung conditions.
Treatment and drugs
Treatment for neuroendocrine cell hyperplasia of infancy centers on oxygen, careful feeding, and medicines to ease breathing symptoms. Some infants also need inhaled therapies or treatment for reflux. Many gradually improve with close follow-up from lung specialists.
Symptoms
Many living with Neuroendocrine cell hyperplasia of infancy have breathing that seems too fast for comfort, even during quiet moments. Early on, this might look like a baby who needs pauses during feeds, seems to work harder to breathe, or gets tired sooner than expected. The early features of Neuroendocrine cell hyperplasia of infancy often show up in the first months of life, but how noticeable they are can vary. Although the breathing pattern can be unsettling, many children improve gradually as they grow.
In Neuroendocrine cell hyperplasia of infancy, one of the clearest signs is breathing faster than expected for age. This may continue even when a baby is calm, resting, or asleep.
The skin may pull in between the ribs, under the rib cage, or at the base of the neck with each breath. Nostrils may flare, and the chest can look as if it is working overtime.
Many children with Neuroendocrine cell hyperplasia of infancy have oxygen levels that run lower than expected, especially during sleep, feeds, or a cold. Sometimes this causes a bluish tinge around the lips, but low oxygen is often picked up only on a monitor.
Feeding can take longer because sucking, swallowing, and breathing all have to stay coordinated. Babies may pause often, tire quickly, or seem sweaty or fussy during a bottle or breastfeed.
How people usually first notice Neuroendocrine cell hyperplasia of infancy?
Neuroendocrine cell hyperplasia of infancy is usually first noticed in the first months of life, when a baby breathes fast, seems to work harder to breathe, or has a crackling sound in the lungs even without a typical infection. Many living with this condition are also first recognized because feeding is tiring, weight gain is slow, or oxygen levels run lower than expected, sometimes leading to a need for extra oxygen. In other words, the first signs of neuroendocrine cell hyperplasia of infancy are often ongoing rapid breathing, mild chest retractions where the skin pulls in between the ribs, and poor growth that does not fully fit with asthma, bronchiolitis, or pneumonia.
Types of Neuroendocrine cell hyperplasia of infancy
No distinct types of Neuroendocrine cell hyperplasia of infancy are widely recognized.
Can I slow down the onset of symptoms?
Probably not. For neuroendocrine cell hyperplasia of infancy, a rare lung condition in babies, there is no good evidence that lifestyle changes or medicines can meaningfully delay when symptoms begin, and this is not something parents cause or can usually prevent. Avoiding cigarette smoke and getting prompt care for colds or chest infections may help protect the lungs after symptoms start, but that is different from preventing the condition, and many children do improve over time even though the timing is hard to predict.
What genetics can tell you about symptoms
For most people with neuroendocrine cell hyperplasia of infancy, genetics does not clearly predict which symptoms they will have, how severe breathing problems will be, or exactly how long symptoms will last. Most cases are not linked to a single known gene change, although rare family patterns suggest that inherited factors may play a role in some children. In practice, this means genetic testing usually cannot forecast the day-to-day symptom pattern, and doctors rely more on symptoms, exam findings, and lung imaging to understand how the condition is affecting a child.
Causes and risk factors
Neuroendocrine cell hyperplasia of infancy seems to begin during early lung development, when too many neuroendocrine cells line the small airways. In many babies, doctors cannot find one clear cause, but the way the lungs formed before birth seems to matter. A small number of children have a family history or a change in the NKX2-1 gene, and doctors are still studying the genetic causes of neuroendocrine cell hyperplasia of infancy. It is rarely just one factor, and the mix matters. Smoke in the home and other air irritants are not known to cause this condition, but they can worsen breathing symptoms and add stress to sensitive lungs.
What are the most common causes or risk factors?
For most babies with neuroendocrine cell hyperplasia of infancy, the exact cause is unknown. The strongest known risk factor is a family history of the condition or a similar lung problem in early childhood, which suggests that inherited gene changes may play a role in some families. So far, doctors have not found clear, proven non-genetic risk factors, and it is not usually linked to anything a parent did during pregnancy or infancy.
Environmental and biological risk factors
The risk factors for neuroendocrine cell hyperplasia of infancy are not as clear as they are for many other lung conditions. Most babies diagnosed with neuroendocrine cell hyperplasia of infancy are in the earliest phase of lung growth, which suggests a body-based developmental process. Researchers are still exploring how outside influences interact with our inner biology. No specific home, pregnancy, or everyday exposure has been proven to cause it.
Neuroendocrine cell hyperplasia of infancy usually begins during infancy, when the lungs are still developing rapidly. This makes early lung maturation the main biological window linked with the condition.
Doctors believe this condition involves an unusual buildup or distribution of certain lung cells during development. That points to an internal lung process rather than a clearly identified outside trigger.
No single environmental exposure has been consistently shown to cause neuroendocrine cell hyperplasia of infancy. Most families did not do anything to bring it on, and routine day-to-day care is not known to be the reason.
Genetic risk factors
When a baby has ongoing fast breathing and low oxygen without a clear reason, many parents wonder if it runs in the family. The genetic causes of Neuroendocrine cell hyperplasia of infancy are still not fully understood, and most babies with Neuroendocrine cell hyperplasia of infancy do not have a single known inherited cause. A small number of family clusters and rare gene findings suggest genetics can matter in some cases, but this condition is usually not tied to one predictable mutation.
Sporadic cases: Most babies with Neuroendocrine cell hyperplasia of infancy are the only affected child in the family. This suggests there is often no clear inherited pattern.
Family history: Rare families have had more than one child or relative with Neuroendocrine cell hyperplasia of infancy or a very similar early lung problem. That pattern points to an inherited tendency in some families, even when the exact gene is still unknown.
NKX2-1 changes: Rare changes in the NKX2-1 gene have been reported in a small number of children with NEHI or a very similar lung disease pattern. Carrying a genetic change doesn’t guarantee the condition will appear. When this gene is involved, doctors may also look for thyroid or movement-related concerns.
Unknown genes: Researchers have not found one main gene that explains most cases of NEHI. This means the genetics are likely more complex than a single inherited change in many families.
Lifestyle risk factors
Neuroendocrine cell hyperplasia of infancy is not caused by lifestyle habits, but daily routines can influence breathing effort, growth, and symptom burden. When people ask about lifestyle risk factors for Neuroendocrine cell hyperplasia of infancy, the key issue is usually how lifestyle affects Neuroendocrine cell hyperplasia of infancy rather than what causes it. The most relevant factors involve feeding, activity pacing, sleep routines, infection-related habits, and avoiding exposures that make breathing harder.
Poor calorie intake can worsen slow weight gain because infants with Neuroendocrine cell hyperplasia of infancy often use extra energy for breathing. Small frequent feeds or nutrition plans guided by the care team may help support growth and reduce fatigue during feeding.
Fast feeding, long feeds, or poor coordination during feeding can increase breathlessness and make it harder for an infant to take in enough nutrition. Pacing feeds, allowing rest breaks, and using techniques recommended by clinicians can lessen feeding-related respiratory strain.
Activity does not cause the condition, but overexertion can increase rapid breathing and oxygen needs in some children with Neuroendocrine cell hyperplasia of infancy. Gentle age-appropriate play with breaks can help support development while avoiding unnecessary respiratory stress.
Irregular sleep or poor sleep quality can leave infants and caregivers more fatigued, which may make feeding and daytime breathing management harder. A calm, consistent sleep routine may help reduce overall strain in children who already breathe quickly at baseline.
Risk prevention
For families affected by neuroendocrine cell hyperplasia of infancy, true prevention of the condition itself is usually not possible. Instead, care focuses on lowering the chance of breathing flare-ups, feeding problems, and poor growth while helping the lungs work as well as possible. Prevention is flexible—it adapts to your life and health background. Many living with neuroendocrine cell hyperplasia of infancy do best with a plan that combines routine medical follow-up and everyday steps at home.
Colds, flu, and other respiratory infections can hit harder in babies and young children with neuroendocrine cell hyperplasia of infancy. Good handwashing, staying away from sick contacts when possible, and keeping routine vaccines up to date can help lower that risk.
Tobacco smoke, vaping aerosol, wood smoke, and strong fumes can irritate sensitive lungs. Keeping indoor air as clean as possible may reduce coughing, fast breathing, and low oxygen levels.
Ongoing follow-up with the child’s medical team helps track breathing, oxygen needs, sleep, and growth over time. Screening and check-ups are part of prevention too.
Many children with neuroendocrine cell hyperplasia of infancy burn extra energy just from breathing faster. Steady feeding support and close growth checks can help prevent poor weight gain and low energy.
Can you prevent Neuroendocrine cell hyperplasia of infancy?
Right now, there is no known way to prevent neuroendocrine cell hyperplasia of infancy, because this rare lung condition in babies usually happens for reasons that are not fully understood and is not thought to be caused by anything a parent did or did not do. In some families, inherited gene changes may play a part, but that does not mean it can be prevented. Usual healthy pregnancy care is still important for overall baby health, but it has not been proven to stop this condition.
Transmission
Neuroendocrine cell hyperplasia of infancy is not an infection, so it does not spread from one baby to another through the air, touch, breast milk, or everyday contact. For families, that means a child with Neuroendocrine cell hyperplasia of infancy is not contagious, even during coughing or breathing problems.
In most children, Neuroendocrine cell hyperplasia of infancy seems to relate to differences in lung development rather than something that was caught, and most cases are not clearly passed down in families. Researchers are still learning how Neuroendocrine cell hyperplasia of infancy is inherited, but rare cases have been linked to gene changes, so genetic counseling may be worth discussing if more than one family member is affected.
When to test your genes
For most infants with neuroendocrine cell hyperplasia of infancy, routine genetic testing is not standard because it usually does not confirm the diagnosis or change treatment. Testing may be considered if breathing problems are unusually severe, the scan pattern is not typical, or there is a family history, to look for other inherited childhood lung diseases that can guide care.
Diagnosis
Neuroendocrine cell hyperplasia of infancy is usually suspected when a baby has ongoing fast breathing, low oxygen levels, or trouble keeping up with feeding and growth. Doctors often piece the diagnosis together from the pattern of symptoms, the exam, and chest imaging rather than from one single test. Some diagnoses are clear after a single visit, while others take more time.
Doctors look closely at breathing rate, feeding, growth, and how much extra effort a baby uses to breathe. The diagnosis of Neuroendocrine cell hyperplasia of infancy often starts with this overall pattern, especially when symptoms continue without a clear infection or heart problem.
Pulse oximetry measures how much oxygen is in the blood at rest, during feeding, and sometimes during sleep. Babies with Neuroendocrine cell hyperplasia of infancy often have lower oxygen levels than expected, which helps show how much the lungs are affected.
A high-resolution CT scan is one of the most useful tests for Neuroendocrine cell hyperplasia of infancy. Doctors look for a typical pattern, often with hazy areas in the right middle lobe and lingula plus signs of air trapping, which can strongly support how Neuroendocrine cell hyperplasia of infancy is diagnosed.
Blood work and other lab tests may help rule out common conditions such as infection, immune problems, or other lung diseases. These tests do not confirm Neuroendocrine cell hyperplasia of infancy by themselves, but they can make other causes less likely.
How is Neuroendocrine cell hyperplasia of infancy diagnosed?
Doctors usually diagnose neuroendocrine cell hyperplasia of infancy by looking at how a baby is breathing, checking oxygen levels, examining the child, and doing tests to rule out more common causes such as infection, heart problems, or other lung diseases. A chest CT scan, which is a detailed imaging test, often shows a pattern that strongly points to this condition. If the answer is still not clear, doctors may use genetic testing to look for other inherited lung problems and sometimes take a small sample of lung tissue to confirm the diagnosis.
Stages of Neuroendocrine cell hyperplasia of infancy
Neuroendocrine cell hyperplasia of infancy does not have defined progression stages. This is because it is not usually tracked as a step-by-step disease that moves through set phases; instead, babies tend to show a pattern of breathing symptoms that can stay fairly similar for a time and then slowly improve as they grow. Often the process begins when you notice changes in daily life, such as fast breathing during feeds, chest pulling in with breaths, or needing extra oxygen. Doctors usually diagnose and monitor it by looking at the early symptoms of neuroendocrine cell hyperplasia of infancy, examining breathing and oxygen levels, and using tests such as a chest CT scan and sometimes bronchoscopy or a lung biopsy if the diagnosis is still unclear.
Outlook and prognosis
Most infants with neuroendocrine cell hyperplasia of infancy improve gradually over time, and the overall prognosis is usually good, although recovery can take months to several years. Many children continue to need supplemental oxygen, inhaled treatments, or close pulmonary follow-up in early childhood, but symptoms and CT abnormalities often lessen with age. Growth and development are often normal, though recurrent respiratory symptoms, exercise limitation, or feeding and sleep-related breathing issues can persist in some cases. Severe progression to respiratory failure is uncommon compared with many other childhood interstitial lung diseases. Death appears to be rare, especially with supportive care and monitoring, but published data are limited because the condition is uncommon. Long-term outcomes can vary depending on the severity at presentation, associated medical problems, and whether complications such as pulmonary hypertension develop.
Long-term effects
For many families, Neuroendocrine cell hyperplasia of infancy affects everyday life most through breathing that stays faster than usual, tiring more easily with activity, and the need for close follow-up over time. The long-term picture is often better than the early symptoms of Neuroendocrine cell hyperplasia of infancy can make it seem, because many children gradually improve through early childhood. Even so, some living with Neuroendocrine cell hyperplasia of infancy continue to have mild breathing or oxygen problems for years, especially during sleep, exercise, or respiratory infections.
Many children improve gradually, but the lungs may take months or years to settle. Fast breathing, chest retractions, or getting winded more easily can last into childhood even as day-to-day symptoms become milder.
Some children need extra oxygen for a long time, especially during sleep or when they have a cold. In others, oxygen can be stopped as they grow, but low oxygen levels may still show up during illness or exertion.
As children get older, some may not keep up as easily with running, sports, or active play. This can reflect mild ongoing lung stiffness or air trapping, even when they seem well at rest.
In infancy, the extra work of breathing can make feeding tiring and weight gain slower. These issues often improve, but some children need time to fully catch up in growth.
How is it to live with Neuroendocrine cell hyperplasia of infancy?
Living with neuroendocrine cell hyperplasia of infancy often means that everyday life is organized around breathing: many babies and young children breathe fast, tire easily with feeding or play, and may need extra calories, oxygen, or closer monitoring, especially during colds and other infections. For families, this can mean frequent medical visits, careful planning around sleep, travel, daycare, and illness exposure, and the emotional strain of watching a child work harder than expected just to do ordinary things. The reassuring part is that many children improve over time, so daily life often becomes easier as the lungs grow, even though progress can be gradual and caregivers usually need strong support along the way.
Treatment and drugs
Neuroendocrine cell hyperplasia of infancy is usually treated by supporting breathing and feeding while the lungs gradually mature, since many babies improve over time rather than needing one single “curative” drug. Treatment often looks different for each person, but it may include extra oxygen, close follow-up with a lung specialist, and help with nutrition if fast breathing makes feeding tiring. Some infants with neuroendocrine cell hyperplasia of infancy are also given medicines to ease breathing symptoms or reduce swelling in the airways, although the benefit of these drugs can vary and care is tailored to how severe symptoms are. In day-to-day life, this can mean home oxygen, regular checkups, and watching for the early symptoms of neuroendocrine cell hyperplasia of infancy getting worse during colds or other infections.
Can you cure Neuroendocrine cell hyperplasia of infancy?
No, there is no cure right now for neuroendocrine cell hyperplasia of infancy, a rare lung condition that affects babies. Treatment is aimed at support, such as extra oxygen, help with feeding and growth, avoiding smoke and lung infections, and regular checkups to watch breathing. Many children slowly improve as they get older, but some may need this support for months or years.
Non-drug treatment
Daily life with neuroendocrine cell hyperplasia of infancy can revolve around fast breathing, low oxygen levels, and tiring easily during feeding or play. Because NEHI mainly affects breathing rather than causing repeated airway infections, care usually focuses on supportive therapies that help babies grow, stay active, and breathe more comfortably. For many, treatment begins not at the pharmacy, but with oxygen support, feeding help, and close follow-up with a lung specialist. Not every approach works the same way, and the mix of therapies often changes as a child grows.
Extra oxygen is one of the main non-drug treatments for NEHI, especially during sleep, feeding, or activity when oxygen levels can dip. It can ease strain on the body and support better growth and energy while the lungs mature.
Many infants with NEHI burn more energy just from breathing, so feeding can become tiring and slow. A dietitian or feeding specialist may suggest higher-calorie feeds, pacing strategies, or tube feeding if weight gain is poor.
Regular visits with a pediatric lung team help track breathing rate, oxygen needs, sleep, and growth over time. This is often how doctors watch for improvement and respond if early symptoms of NEHI are limiting daily activities more than expected.
Gentle activity is usually encouraged, but many living with NEHI need breaks because they tire more quickly than other children. Physical or developmental therapy can help support movement, stamina, and everyday play without pushing past breathing limits.
Your genes may have an impact on how drugs work for you
For babies and children living with neuroendocrine cell hyperplasia of infancy, treatment is usually supportive, such as extra oxygen and close follow-up, rather than medicines that need to be matched to someone’s genes. At this time, there is no well-established evidence that common genetic differences change how children with this condition respond to the treatments most often used, and gene-based drug matching is not a routine part of care. Some children may still respond differently to medicines tried for cough, wheeze, or breathing trouble, but doctors usually base those choices on symptoms and how the child is doing day to day, not on genetic test results.
Pharmacological treatments
For many families, the treatment for neuroendocrine cell hyperplasia of infancy is mostly supportive, because no medicine has been proven to correct the underlying lung changes. Most infants are managed with oxygen, careful feeding support, and close follow-up, while medicines are used only in selected situations. Not everyone responds to the same medication in the same way.
There is no established medicine that reliably treats neuroendocrine cell hyperplasia of infancy itself. Care usually focuses on easing breathing strain and supporting growth rather than using a disease-specific drug.
Inhaled bronchodilators such as albuterol may be tried if a child also has wheezing or airway tightening. They often do not make a clear difference in NEHI, so doctors usually continue them only if there is a noticeable benefit.
Corticosteroids, including prednisone or inhaled steroids like budesonide or fluticasone, have not shown consistent benefit for most infants with NEHI. Because of possible side effects, they are not routine treatment unless another reason to use them is present.
Antibiotics such as amoxicillin or azithromycin are not used to treat NEHI itself. They are given only when a bacterial infection, such as pneumonia or an ear infection, is suspected or confirmed.
Genetic influences
For most families, the exact cause of Neuroendocrine cell hyperplasia of infancy is still not fully understood. Researchers think genes may matter in some cases because a small number of families have had more than one child with a similar lung condition. Family history is one of the strongest clues to a genetic influence. Even so, Neuroendocrine cell hyperplasia of infancy is not usually linked to one clearly established gene in the way some inherited disorders are. If a baby’s symptoms or scan results do not fit the usual pattern, doctors may look for other genetic lung conditions that can resemble NEHI and may run in families. This can help answer questions about the genetic causes of Neuroendocrine cell hyperplasia of infancy and guide testing or genetic counseling when needed.
Is Neuroendocrine cell hyperplasia of infancy genetic?
For neuroendocrine cell hyperplasia of infancy, genetics are usually not the main driver. Most cases are sporadic, but a small number may be linked to gene changes, especially NKX2-1, so genetic testing is sometimes considered.
Having a genetic risk is not necessarily a diagnosis
Genetic variants are a usual part of human biology and are common across the general population. Most do not have a direct effect on health and simply reflect normal human diversity. For many genes, having a variant connected with a condition suggests a possible association rather than a definite diagnosis, especially when several genes and environmental factors are involved. In some cases, though, one well-understood variant in a particular gene is enough to confirm a diagnosis.
Pharmacogenetics—how genetics influence drug effects
For families managing fast breathing, low oxygen levels, and long feeds, treatment for neuroendocrine cell hyperplasia of infancy usually focuses on oxygen support, good nutrition, and close follow-up rather than on a medicine chosen by genetic testing. At this point, there is no well-established drug-response gene test that tells doctors which medication will work best for neuroendocrine cell hyperplasia of infancy or what dose to use. Genetics is only one factor, and in NEHI the main value of genetic testing is often to help confirm the diagnosis or look for a rare related gene change that could affect other parts of the body too. That can matter because it may lead the care team to watch for additional health issues instead of assuming every symptom comes from the lungs alone. Some medicines, including steroids, often do not help typical NEHI, so treatment decisions are guided more by how a child is breathing, growing, and handling daily activity than by known genetic differences in drug response.
Interactions with other conditions
Many living with Neuroendocrine cell hyperplasia of infancy have fast breathing, low oxygen levels, or feeding struggles, and these can become more noticeable during a cold or other viral chest infection. The early symptoms of Neuroendocrine cell hyperplasia of infancy can also look a lot like asthma, reflux, or swallowing problems, so it may take time to sort out what is coming from the lung condition itself and what may be happening alongside it. Doctors call it a comorbidity when two conditions occur together. In practice, that matters because reflux, poor weight gain, or repeated respiratory infections can add to breathing trouble and make daily care more demanding.
Some infants with Neuroendocrine cell hyperplasia of infancy are also evaluated for other lung or heart problems if symptoms seem more severe than expected. Interactions can look very different from person to person, and not every child with Neuroendocrine cell hyperplasia of infancy has another condition. Because symptoms can overlap, follow-up with a pediatric lung specialist is important so treatment targets the right problem and any added illness is not missed.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
What other conditions can cause similar symptoms to Neuroendocrine cell hyperplasia of infancy?
Neuroendocrine cell hyperplasia of infancy can look a lot like more common problems, especially asthma, bronchiolitis, repeated chest infections such as pneumonia, or swallowing and reflux problems that let milk or food go into the lungs. Doctors may also need to rule out cystic fibrosis, some heart problems, and other rare long-term lung conditions in babies, because these can also cause fast breathing, pulling in of the chest, poor weight gain, and low oxygen levels. The right diagnosis often depends on the full pattern over time, not just one symptom.
History
Neuroendocrine cell hyperplasia of infancy, often shortened to NEHI, came into medical focus because some babies had the same puzzling pattern: fast breathing, a crackly sound in the lungs, and trouble keeping up with feeding or weight gain, even though common infections or heart problems did not fully explain what was going on. For families, this could mean months of worry over a baby who seemed to breathe hard during everyday moments like feeding, crying, or sleeping.
Doctors first recognized this pattern more clearly in the late 20th and early 21st centuries, when improved imaging and careful review of lung tissue helped separate NEHI from other childhood lung diseases. Once considered rare, now recognized as a distinct condition, NEHI was identified as one of several disorders that affect the small airways and air sacs in infants. This mattered because it helped explain why some children were being treated for more familiar lung illnesses without much improvement.
As medical science evolved, specialists learned that NEHI often has a characteristic appearance on chest scans, especially in the middle parts of the lungs, which meant some babies could be diagnosed without more invasive testing. Over time, this changed care in a practical way: families could get answers sooner, and doctors could focus more on monitoring breathing, growth, and oxygen needs rather than assuming the problem was repeated infection. Researchers later identified that NEHI can have a genetic basis in some families, but the history of the condition is mostly the story of better recognition.
That growing recognition has also changed expectations. Early descriptions of neuroendocrine cell hyperplasia of infancy often came from children with more obvious symptoms, so the first picture of the condition was not always complete. Now clinicians understand that severity can vary. Some infants need extra oxygen for a time, while others have milder symptoms. This broader view has helped families and care teams better understand the early symptoms of Neuroendocrine cell hyperplasia of infancy and how the condition may unfold over time.